PEMPHIGUS VULGARIS
Clinical trials for PEMPHIGUS VULGARIS explained in plain language.
Never miss a new study
Get alerted when new PEMPHIGUS VULGARIS trials appear
Sign up with your email to follow new studies for PEMPHIGUS VULGARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune cell therapy targets rare blistering disease
Disease control Recruiting nowThis study tests two types of engineered immune cells (CAR T-cells) in people with active pemphigus vulgaris, a painful blistering skin condition. The goal is to see if these cells can safely control the disease by targeting faulty immune cells. About 40 adults will take part, an…
Matched conditions: PEMPHIGUS VULGARIS
Phase: PHASE1, PHASE2 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated May 26, 2026 09:44 UTC
-
Researchers track blistering skin disease to pave way for better treatments
Knowledge-focused Recruiting nowThis study aims to better understand how severe autoimmune blistering diseases like pemphigus and bullous pemphigoid are, and how they affect quality of life. Researchers will enroll 150 adults with these conditions to measure disease activity and daily impact. The goal is to imp…
Matched conditions: PEMPHIGUS VULGARIS
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 26, 2026 09:26 UTC